Abstract
Ruthenium-based compounds represent a class of potential antineoplastic drugs. Recently, we designed, synthesized, and identified the Ru(II)-thymine complex [Ru(PPh₃)₂(Thy)(bipy)]PF₆ (where PPh = triphenylphosphine, Thy = thymine and bipy = 2,2'-bipyridine) as a potent cytotoxic agent with the ability to bind to DNA and human and bovine serum albumins. In this study, the underlying cytotoxic mechanism of the [Ru(PPh₃)₂(Thy)(bipy)]PF₆ complex was assessed. This complex displayed potent cytotoxicity in different cancer cell lines; the morphology that is associated with apoptotic cell death, increased internucleosomal DNA fragmentation without cell membrane permeability, loss of the mitochondrial transmembrane potential, increased phosphatidylserine externalization, and caspase-3 activation were observed in human promyelocytic leukemia HL-60 cells that were treated with the complex. Moreover, pretreatment of HL-60 cells with Z-VAD(OMe)-FMK, a pan-caspase inhibitor, partially reduced the apoptosis that was induced by the complex, indicating that the apoptotic cell death occurred through a caspase-mediated pathway. In conclusion, the [Ru(PPh₃)₂(Thy)(bipy)]PF₆ complex displays potent cytotoxicity to different cancer cells and induces...Continue Reading
References
Mar 1, 1992·Chemical Research in Toxicology·C P LeBelS C Bondy
Jun 3, 1991·Journal of Immunological Methods·I NicolettiC Riccardi
Apr 15, 1994·Journal of Immunological Methods·S A AhmedJ E Walsh
May 1, 1997·Cytometry·F X SuredaA Camins
Feb 5, 1998·Cytometry·M van EngelandC P Reutelingsperger
Sep 15, 2006·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Daniel Pereira BezerraLetícia Veras Costa-Lotufo
Feb 12, 2009·Anti-cancer Drugs·Frederike LentzUNKNOWN Central European Society for Anticancer Drug Research-EWIV
Oct 4, 2012·Cell Proliferation·L OuyangJ-K Bao
Jun 13, 2013·Toxicology and Applied Pharmacology·Hemerson I F MagalhãesClaudia Pessoa
Oct 26, 2014·Investigational New Drugs·Suzanne LeijenJan H M Schellens
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Jan 15, 2016·Scientific Reports·Leli ZengHui Chao
Jan 18, 2016·Journal of Inorganic Biochemistry·Chuping ZhengJie Liu
May 24, 2016·International Journal of Molecular Sciences·Yiyu LuWeiguang Gu
Nov 5, 2016·Oncotarget·Lanmei ChenBilian Xu
Mar 25, 2017·Biomaterials·Zhiqin DengTianfeng Chen
May 5, 2017·Journal of Inorganic Biochemistry·Dan WanYun-Jun Liu
Jul 7, 2017·Chemical Communications : Chem Comm·B SiewertS Bonnet
Sep 4, 2017·Journal of Inorganic Biochemistry·Katia M OliveiraAlzir A Batista
Sep 20, 2017·European Journal of Medicinal Chemistry·Jincan ChenLanmei Chen
Dec 22, 2017·Oncotarget·Cinara O D'Sousa CostaDaniel P Bezerra
Jan 13, 2018·Scientific Reports·Valdenizia Rodrigues SilvaDaniel Pereira Bezerra
Jan 25, 2018·Cell Death & Disease·Nanashara C de CarvalhoDaniel P Bezerra
Jan 25, 2018·Cell Death and Differentiation·Lorenzo GalluzziGuido Kroemer
Jan 25, 2018·Oxidative Medicine and Cellular Longevity·Luciano de Souza SantosDaniel Pereira Bezerra
Feb 9, 2018·Oncotarget·Seong-Hoon YunJoo-In Park
Feb 24, 2018·Scientific Reports·Andrana Karla CalgarottoSara Teresinha Olalla Saad
Citations
Jul 25, 2019·Frontiers in Oncology·Ingrid R S BalizaDaniel P Bezerra
Jul 25, 2019·Frontiers in Oncology·Sara P NevesDaniel P Bezerra
Aug 2, 2019·Scientific Reports·Suellen L R SilvaDaniel P Bezerra
Sep 23, 2020·Scientific Reports·Mônica Soares CostaKelly Aparecida Geraldo Yoneyama
Aug 9, 2019·Scientific Reports·Larissa M BomfimDaniel P Bezerra
Nov 18, 2018·Journal of Ethnopharmacology·Ana Carolina B da C RodriguesDaniel P Bezerra